[Temporary Announcement] Xinghao Pharmaceutical: 2025 Annual Report Briefing Preview Announcement
Securities code: 920017 Securities abbreviation: Xinghao Pharmaceutical Announcement number: 2026-040
Beijing Xinghao Pharmaceutical Co., Ltd.
2025 Annual Report Briefing Preview Announcement
The company and all members of the board of directors guarantee that the contents of the announcement are true, accurate and complete, and that there are no false records, misleading statements or major omissions, and bear individual and joint legal liability for the authenticity, accuracy and completeness of the contents.
1. Type of briefing session
Beijing Xinghao Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") released the "2025 Annual Report" (announcement number: 2026-009) on the official information disclosure platform of the Beijing Stock Exchange (http://www.bse.cn) on April 24, 2026. In order to facilitate investors to have a deeper understanding of the company's specific operating performance in 2025 and strengthen interaction with investors, the company plans to hold a 2025 annual report briefing meeting. (cid:13)
2. Time and place of the briefing meeting
(1) Meeting time: May 8, 2026 (Friday) 15:00-17:00.
(2) Place of meeting
This annual report performance briefing will be held remotely via the Internet. Investors can log in to Panorama's "Investor Relations Interactive Platform" (https://ir.p5w.net) to participate in this performance briefing.
3. Participants
Company Chairman: Ms. Yin Lan
General Manager of the Company: Mr. Yu Jizhong
Secretary of the Company’s Board of Directors: Ms. Wen Qian
Financial person in charge of the company: Mr. Wu Hao
Sponsor representative: Mr. Qiu Chen
4. How to participate as an investor
This briefing will be held online.
In order to fully respect investors and improve the pertinence of communication, we are now publicly soliciting questions from investors in advance for the company's 2025 annual report online briefing session to widely listen to investors' opinions and suggestions. Investors can visit http://ir.p5w.net/zj/ before 15:00 on May 8, 2026 (Friday) and enter the special question collection page to ask questions. The company will answer questions of common concern to investors at this annual reporting industry briefing.
(QR code on the special page of question collection)
5. Contact Information
Contact person: Wen Qian
Contact address: Conference Room, No. 1, Zhongjing West Road, Daxing District, Beijing
Contact number: 010-67881088
Postal code: 100176
Announcement is hereby made.
Board of Directors of Beijing Xinghao Pharmaceutical Co., Ltd.
April 28, 2026